Ticker
CPIXCompany Name
CUMBERLAND PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 48.32M | $ 4.82M | $ -10.85M | $ 0 | 12.49% |
3/31/2025 | $ 70.32M | $ 4.69M | $ -10.84M | $ 0 | 8.75% |
12/31/2024 | $ 88.98M | $ -579.05K | $ 2.49M | $ 0 | -2.15% |
9/30/2024 | $ 16.71M | $ -669.64K | $ 3.17M | $ 0 | -14.95% |
6/30/2024 | $ 20.14M | $ -772.47K | $ 2.94M | $ 0 | -10.78% |
3/31/2024 | $ 21.85M | $ -801.02K | $ 11.86K | $ 0 | 3.61% |
12/31/2023 | $ 25.66M | $ -740.53K | $ -3.42M | $ 0 | 16.2% |
9/30/2023 | $ 22.95M | $ -741.22K | $ -4.78M | $ 0 | 24.04% |
6/30/2023 | $ 24.72M | $ -614.66K | $ -5.85M | $ 0 | 26.16% |
3/31/2023 | $ 23.84M | $ -660.03K | $ -3.93M | $ 0 | 19.24% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for CUMBERLAND PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ -2.45M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -3M ]) / Market Cap [ $ 45.11M ]
(=) Shareholder Yield [ 12.09% ]
Minimum
Sep 30, 2024
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |